(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

AUTOLUSASSIST

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

AUTOLUSASSIST

ST13

US500000079420600

Classe

9, 41, 42, 44

Pedido

79420600

Registro

8090730

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

22

Atualização mais recente

06/08/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

9, 41, 42, 44

Data de depósito

08/11/2024

Data de registro

06/01/2026

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

06/01/2026

Última transação

06/08/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

99

Localização do titular

GB

Examinador

HARMON, RAYMOND E

Unidade examinadora

L30

Localização atual

FILE REPOSITORY (FRANCONIA)

Titulares e representantes

Titulares

Autolus Limited

Representantes

Rebecca Liebowitz Venable LLP

Classificação técnica

Classes Nice

Classe 9Classe 41Classe 42Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 9

Downloadable mobile applications for use in enabling healthcare professionals and patients to access information on pharmaceutical and medical related products and services.

Classe 41

Educational servicesin particulartraining and coaching services in the field of medical diseases and disorders and their treatment; arrangingorganising and conducting events for educational purposes related to oncologyautoimmune diseasesimmunotherapy and cell therapy

Classe 42

Hosting a website featuring non-downloadable software for use as a digital platform tailored to healthcare professionals and patients for facilitating web-based appointment schedulingmedical consultationmedical examinationhealth assessmenthealth educationsupervisingmonitoring and treatment of patients in a remote settingcoordinating patients' care and medical resourcessecure messaging to patients and healthcare providers; software as a service(SaaS) services featuring software for use as a digital platform tailored to healthcare professionals and patients for facilitating web based appointment schedulingmedical consultationmedical examinationhealth assessmenthealth educationsupervisingmonitoring and treatment of patients in a remote settingcoordinating patients' care and medical resourcessecure messaging to patients and healthcare providers; platform as a service (PaaS) services featuring computer software platforms tailored to healthcare professionals and patients for facilitating web-based appointment schedulingmedical consultationmedical examinationhealth assessmenthealth educationsupervisingmonitoring and treatment of patients in a remote settingcoordinating patients' care and medical resourcessecure messaging to patients and healthcare providers; provision of scientific information via an internet portal

Classe 44

Medical and healthcare services; providing medical information related to healthcarepharmaceutical productsvaccinesdiseases and disorders and treatment options via a website and platform; medical services related to providing support for patients and healthcare providers featuring information in the field of healthcareoncologyautoimmune diseasesimmunotherapycell therapy and pharmaceutical products via a website and platform; providing medical information via a websitenamely clinical and medical informationincluding providing advice on patient specific pharmaceuticals and cell therapiesdisease monitoring and treatment in the field of oncologyautoimmune diseasesimmunotherapy and cell therapy; provision of medical informationconsultancy and advisory services relating to all of the aforesaid services

Publicações

Histórico de despachos e eventos da marca no USPTO.

22 publicações encontradas

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

06/08/2026

FICS

FINAL DISPOSITION NOTICE SENT TO IB

17/07/2026

FIMP

FINAL DISPOSITION PROCESSED

17/07/2026

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

06/04/2026

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

06/01/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

06/01/2026

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

18/11/2025

PUBO

PUBLISHED FOR OPPOSITION

18/11/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/11/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

22/10/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

22/10/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

20/10/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

20/10/2025

RFNT

REFUSAL PROCESSED BY IB

12/07/2025

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

21/06/2025

RFRR

REFUSAL PROCESSED BY MPU

21/06/2025

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

18/04/2025

CNRT

NON-FINAL ACTION WRITTEN

17/04/2025

DOCK

ASSIGNED TO EXAMINER

09/04/2025

MAFR

APPLICATION FILING RECEIPT MAILED

04/04/2025

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/04/2025

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

03/04/2025

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace AUTOLUSASSIST ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.